Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Zuckerman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Arthritis Research & Therapy|July 27, 2014
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trialsJohn D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, et al.
Fertility and Sterility|November 10, 2021
ASRM müllerian anomalies classification 2021Samantha M Pfeifer, Marjan Attaran, Jessica Goldstein, et al.
Annals of the Rheumatic Diseases|March 14, 2013
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised studyIain B McInnes, Ho-Youn Kim, Sang-Heon Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinibChristina Charles-Schoeman, Roy Fleischmann, Jean Davignon, et al.
Arthritis Research & Therapy|April 19, 2015
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialJoel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Arthritis Research & Therapy|July 27, 2014
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trialsJohn D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, et al.
Fertility and Sterility|November 10, 2021
ASRM müllerian anomalies classification 2021Samantha M Pfeifer, Marjan Attaran, Jessica Goldstein, et al.
Annals of the Rheumatic Diseases|March 14, 2013
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised studyIain B McInnes, Ho-Youn Kim, Sang-Heon Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinibChristina Charles-Schoeman, Roy Fleischmann, Jean Davignon, et al.
Arthritis Research & Therapy|April 19, 2015
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialJoel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, et al.
Pageof 2